TGFB1 and ovarian carcinoma: Single-cell RNA sequencing, single-cell chromatin and spatial transcriptomic technologies now permit direct quantification of TGF-β pathway activity, fibroblast and extracellular-matrix programs, and ligand–receptor interactions that organize T-cell exclusion in ovarian cancer (22–24).